Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally critical role in supporting the most revolutionary technology the world’s ever seen… artificial intelligence. And without it, the entire AI industry would collapse.

You must read this new presentation from Porter Stansberry.

Matthias Bodenstedt net worth and biography

Matthias Bodenstedt Biography and Net Worth

CFO of MoonLake Immunotherapeutics

Matthias Bodenstedt, is the Chief Financial Officer of MoonLake since July 2021, and is Director of MoonLake Immunotherapeutics Ltd. since September 2021. Prior to MoonLake, Mr. Bodenstedt was a Partner at McKinsey & Company, Inc. (Switzerland), where from September 2015 to June 2021 he advised a diverse set of clients, ranging from pre-revenue biotechs to large global pharmaceutical companies, on many industry-shaping transactions on the sell- and buy-side, and worked closely with senior executives on topics such as financing, M&A, BD&L, portfolio strategy, and go-to-market strategy and execution. Mr. Bodenstedt holds an M.B.A. from Columbia Business School (New York), MPhil Finance from the University of Cambridge (United Kingdom), and B.Sc. Industrial Engineering from the University of Hannover (Germany).

What is Matthias Bodenstedt's net worth?: The estimated net worth of Matthias Bodenstedt is at least $28.58 million as of December 19th, 2023. Mr. Bodenstedt owns 526,167 shares of MoonLake Immunotherapeutics stock worth more than $28,581,391 as of November 23rd. This net worth estimate does not reflect any other investments that Mr. Bodenstedt may own. Additionally, Mr. Bodenstedt receives a salary of $588,250.00 as CFO at MoonLake Immunotherapeutics. Learn More about Matthias Bodenstedt's net worth.
How old is Matthias Bodenstedt?: Mr. Bodenstedt is currently 36 years old. There are 2 older executives and no younger executives at MoonLake Immunotherapeutics. The oldest executive at MoonLake Immunotherapeutics is Dr. Kristian Reich, Co-Founder & Chief Scientific Officer, who is 58 years old. Learn More on Matthias Bodenstedt's age.
What is Matthias Bodenstedt's salary?: As the CFO of MoonLake Immunotherapeutics, Mr. Bodenstedt earns $588,250.00 per year. There are 2 executives that earn more than Mr. Bodenstedt. The highest earning executive at MoonLake Immunotherapeutics is Dr. Kristian Reich, Co-Founder & Chief Scientific Officer, who commands a salary of $1,200,000.00 per year. Learn More on Matthias Bodenstedt's salary.
How do I contact Matthias Bodenstedt?: The corporate mailing address for Mr. Bodenstedt and other MoonLake Immunotherapeutics executives is , , . MoonLake Immunotherapeutics can also be reached via phone at 41-41-510-8022 and via email at [email protected]. Learn More on Matthias Bodenstedt's contact information.
Has Matthias Bodenstedt been buying or selling shares of MoonLake Immunotherapeutics?: Matthias Bodenstedt has not been actively trading shares of MoonLake Immunotherapeutics during the past quarter. Most recently, Matthias Bodenstedt sold 94,736 shares of the business's stock in a transaction on Tuesday, December 19th. The shares were sold at an average price of $59.22, for a transaction totalling $5,610,265.92. Following the completion of the sale, the chief financial officer now directly owns 526,167 shares of the company's stock, valued at $31,159,609.74. Learn More on Matthias Bodenstedt's trading history.
Who are MoonLake Immunotherapeutics' active insiders?: MoonLake Immunotherapeutics' insider roster includes Matthias Bodenstedt (CFO), and Simon Sturge (Director). Learn More on MoonLake Immunotherapeutics' active insiders.
Are insiders buying or selling shares of MoonLake Immunotherapeutics?: In the last twelve months, insiders at the sold shares 10 times. They sold a total of 432,717 shares worth more than $24,287,059.52. The most recent insider tranaction occured on October, 4th when Director Simon Sturge sold 171,000 shares worth more than $9,186,120.00. Insiders at MoonLake Immunotherapeutics own 12.0% of the company. Learn More about insider trades at MoonLake Immunotherapeutics.
Information on this page was last updated on 10/4/2024.

Matthias Bodenstedt Insider Trading History at MoonLake Immunotherapeutics

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
12/19/2023	Sell	94,736	$59.22	$5,610,265.92	526,167

Matthias Bodenstedt Buying and Selling Activity at MoonLake Immunotherapeutics

MoonLake Immunotherapeutics Company Overview

MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It develops Sonelokimab, a novel investigational Nanobody for the treatment of inflammation diseases; and hidradenitis suppurativa, psoriatic arthritis, axial spondyloarthritis, and psoriasis. MoonLake Immunotherapeutics was incorporated in 2020 and is headquartered in Zug, Switzerland.

Today's Range

Now: $54.32

$51.43

$54.91

50 Day Range

MA: $50.05

$46.20

$55.40

2 Week Range

Now: $54.32

$37.55

$64.98

Volume

223,381 shs

Average Volume

370,444 shs

Market Capitalization

$3.47 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.28

This company will win the AI race

From Porter & Company | Ad

You must read this new presentation from Porter Stansberry.

Matthias Bodenstedt Biography and Net Worth

What is Matthias Bodenstedt's net worth?

How old is Matthias Bodenstedt?

What is Matthias Bodenstedt's salary?

How do I contact Matthias Bodenstedt?

Has Matthias Bodenstedt been buying or selling shares of MoonLake Immunotherapeutics?

Who are MoonLake Immunotherapeutics' active insiders?

Are insiders buying or selling shares of MoonLake Immunotherapeutics?